PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
06-Feb-2023 Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline Synaffix B.V.
06-Feb-2023 Endogena Therapeutics Receives US FDA Fast Track Designation for EA-2353 for the Treatment of Endogena Therapeutics Inc
06-Feb-2023 Alfa Chemistry Now Becomes A High-Quality 2D Material Supplier Alfa Chemistry
03-Feb-2023 SCOTTISH BIOTECH COMPANY ANNOUNCES DRAMATIC BREAKTHROUGH IN BATTLE AGAINST COVID-19 ILC Therapeutics
01-Feb-2023 Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer Avectas
31-Jan-2023 The Future of BioPharma Industry: Challenges and Opportunities Jubilant Biosys
29-Jan-2023 MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research CD Genomics
29-Jan-2023 CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research CD Genomics
29-Jan-2023 CD Genomics Introduces Professional and Mature Long Amplicon Analysis Service CD Genomics
26-Jan-2023 AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial AC Immune SA
26-Jan-2023 Cherwell publishes new guide to EM best practice in compliance with revised Annex 1 Cherwell Laboratories
26-Jan-2023 Future of clinical research in the NHS in jeopardy without urgent action, warns Lords Committee House of Lords
26-Jan-2023 Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast Almac Group
26-Jan-2023 New spray fights infections and antibiotic resistance The World Health Organization
26-Jan-2023 Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107 Douglas Pharmaceuticals
26-Jan-2023 ONXEO provides update on the Development Program for its first-in-class drug candidate AsiDNATM Onxeo
26-Jan-2023 Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease Orbsen Therapeutics Limited
26-Jan-2023 Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III Novartis
26-Jan-2023 First CAR T-cell therapy recommended for routine use on the NHS in England Gilead Sciences Ltd
26-Jan-2023 Blackford and Brainomix Announce AI Partnership for Stroke Care Blackford